Skip to main content
Clinical Trials/NCT04083742
NCT04083742
Completed
Not Applicable

The Heidelberg Engineering ANTERION Anterior Segment Metrics Precision and Agreement Study

Heidelberg Engineering GmbH1 site in 1 country59 target enrollmentAugust 22, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Narrow Angle
Sponsor
Heidelberg Engineering GmbH
Enrollment
59
Locations
1
Primary Endpoint
Repeatability and Reproducibility 2
Status
Completed
Last Updated
last year

Overview

Brief Summary

This is a prospective clinical study that will be conducted at one clinical site located in the United States to assess anterior segment metrics with the ANTERION

Registry
clinicaltrials.gov
Start Date
August 22, 2019
End Date
December 31, 2023
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age 22 years or older
  • Able and willing to undergo the test procedures, sign informed consent, and follow instructions
  • Able to fixate
  • With at least one of following eye status for the corresponding eye population:
  • A. Eye with Open Angle (defined by Spaeth gonioscopy grading)
  • B. Eye with Narrow Angle (defined by Spaeth gonioscopy grading)

Exclusion Criteria

  • Subjects which were enrolled in the B-2018-1 study
  • Active infection or inflammation in either eye
  • Insufficient tear film or corneal reflex
  • Physical inability to be properly positioned at the study devices or eye exam equipment
  • Rigid contact lens wear during 2 weeks prior to day when study device acquisitions take place
  • Soft lenses worn within one hour prior to study device acquisitions

Outcomes

Primary Outcomes

Repeatability and Reproducibility 2

Time Frame: 1 day

Reproducibility and repeatability of Angle to Angle distance parameter \[mm\] of ANTERION and the reference device

Agreement 1

Time Frame: 1 day

Agreement of Spur to Spur distance parameter \[mm\] between the ANTERION and the reference device

Agreement 2

Time Frame: 1 day

Agreement of Angle to Angle distance parameter \[mm\] between the ANTERION and the reference device

Agreement 3

Time Frame: 1 day

Agreement of Lens Vault parameter \[µm\] between the ANTERION and the reference device

Agreement 5

Time Frame: 1 day

Agreement of TISA parameters \[mm2\] between the ANTERION and the reference device

Repeatability and Reproducibility 5

Time Frame: 1 day

Reproducibility and repeatability of TISA parameters \[mm2\] of ANTERION and the reference device

Repeatability and Reproducibility 6

Time Frame: 1 day

Reproducibility and repeatability of AOD parameters \[µm\] of ANTERION and the reference device

Agreement 6

Time Frame: 1 day

Agreement of AOD parameters \[µm\] between the ANTERION and the reference device

Repeatability and Reproducibility 1

Time Frame: 1 day

Reproducibility and repeatability of Spur to Spur distance parameter \[mm\] of ANTERION and the reference device

Repeatability and Reproducibility 3

Time Frame: 1 day

Reproducibility and repeatability of Lens Vault parameter \[µm\] of ANTERION and the reference device

Repeatability and Reproducibility 4

Time Frame: 1 day

Reproducibility and repeatability of Anterior Segment Angles parameter \[°\] of ANTERION and the reference device

Agreement 4

Time Frame: 1 day

Agreement of Anterior Segment Angles parameter \[°\] between the ANTERION and the reference device

Secondary Outcomes

  • Adverse Events Rate(1 day)

Study Sites (1)

Loading locations...

Similar Trials